SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapy

Autor: Alexander L. Greninger, Richard K. Plemper, Katherine S. Lee, Ting Y. Wong, Michael T. Winters, Brynnan P. Russ, Fredrick Heath Damron, James Denvir, Justin R. Bevere, Luis Martinez-Sobrido, Jordi B. Torrelles, Ivan Martinez, Holly A. Cyphert, Julien Sourimant, Alexander M. Horspool, Chengjin Ye, Theodore Kieffer
Rok vydání: 2021
Předmět:
Zdroj: bioRxiv
DOI: 10.1101/2021.05.05.442784
Popis: SUMMARYSARS-CoV-2 variants of concern (VoCs) are impacting responses to the COVID-19 pandemic. Here we present a comparison of the SARS-CoV-2 USA-WA1/2020 (WA-1) strain with B.1.1.7 and B.1.351 VoCs and identify significant differences in viral propagationin vitroand pathogenicityin vivousing K18-hACE2 transgenic mice. Passive immunization with plasma from an early pandemic SARS-CoV-2 patient resulted in significant differences in the outcome of VoC-infected mice. WA-1-infected mice were protected by plasma, B.1.1.7-infected mice were partially protected, and B.1.351-infected mice were not protected. Serological correlates of disease were different between VoC-infected mice, with B.1.351 triggering significantly altered cytokine profiles than other strains. In this study, we defined infectivity and immune responses triggered by VoCs and observed that early 2020 SARS-CoV-2 human immune plasma was insufficient to protect against challenge with B.1.1.7 and B.1.351 in the mouse model.
Databáze: OpenAIRE